Manipulating the immune system by interleukin-2 (IL-2) based immunotherapy may induce durable tumour regression in metastatic renal cell carcinoma (mRCC) (Minasian et al, 1993; Fyfe et al, 1995; Jeal ...
Breast cancer (BC) drives the highest incidence of cancer-related deaths in women and affects yearly more than 464,000 new patients in Europe 1. Since the early 1970s, the survival rates have ...